Tumor necrosis factor-α and interferon-γ, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10

Leukemia and Lymphoma

Volumn 29, Issue 3-4, 1998, Pages 315-328

  Daliani, Danai ^a   Ulmer, Rose Ann ^b   Jackow, Clotilde ^b   Pugh, William ^a   Gansbacher, Bernd ^c   Cabanillas, Fernando ^a   Duvic, Madeleine ^a,b   Sarris, Andreas H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cutaneous t cell lymphoma; Epidermotropism; HTLV I tax; Interferon inducible protein 10; Interferon ; Ip 10; TNF

Indexed keywords

ACTIN; GAMMA INTERFERON; MESSENGER RNA; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0031845905     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809068568     Document Type: Article

References (55)

1. Hoppe, R. T., Wood, G. S. and Abel, E. A. (1990). Mycosis fungoides and the Sezary syndrome: pathology, staging and treatment. Current Problems in Cancer, XIV, 295-361.
2. Weiss, L. M., Hu, E., Wood, G. S., Moulds, C., Cleary, M. L., Warnke, R. and Sklar, J. (1985). Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med, 313, 539-44.
3. Ramsay, D. L., Meller, J. A. and Zackheim, H. S. (1995). Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9, 1031-56.
4. Kaye, F. J., Bunn, P. J., Steinberg, S. M., Stocker, J. L., Ihde, D. C., Fischmann, A. B., Glatstein, E. J., Schechter, G. P., Phelps, R. M., Foss, F. M., Parlette, H. L., III, Anderson, M. J., Sausvilie, E. A. (1989). A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides N Engl J Med, 321, 1748-90
5. Dmitrovsky, E., Matthews, M. J., Bunn, P. A., Schechter, G. P., Makuch, R. W., Winkler, C. F., Eddy, J., Sausville, E. A. and Ihde, D. C. (1987). Cytologic transformation in cutaneous T-cell lyphoma : a clinipathologic entity associated with poor prognosis. J Clin Oncol, 5, 208-15.
6. Salhany, K. E., Cousar, J. B., Greer, J. P., Casey, T. T., Fields, J. P. and Collins, R. D. (1988). Transformation of cutaneous T-cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study, Am J Pathol, 132 265-77.
7. Greer, J. P., Salhany, K. E., Cousar, J. B., Fields, J. P., King, L. E., Graber, S. E., Flexner, J. M., Stein, R. S. and Collins, R. D. (1990). Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol, 8, 215-27.
8. Cerroni, L., Rieger, E., Hodl, S. and Kerl, H. (1992). Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol, 16, 543-52.
9. Springer, T. A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-14.
10. Luster, A. D., Unkeless, J. C. and Ravetch, J. V. (1985). Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature, 315, 672-6.
11. Sams, A. H., Broxmeyer, H. E., Wirthmueller, U., Karasavvas, N., Cooper, S., Lu, L., Krueger, J. and Ravetch, J. V. (1993). Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J Exp Med, 178, 1127-32
12. Taub, D. D., Longo, D. L. and Murphy, W. J. (1996). Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T-lymphocytes into the peripheral tissues of human peripheral blood lymphocytes-SCID mice. Blood, 87, 1423-1431.
13. + T cells in response to MIP-1 alpha and MIP-1 beta. Science, 260, 355-8.
14. Broxmeyer, H. E., Cooper, S., Hague, N., Benninger, L., Sarris, A., Cornetta, K., Vadham-Raj, S., Hendrie, P. and Mantel, C. (1995). Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Annals of Hematology, 71, 235-246.
15. Sarris, A. H., Talpaz, M., Deisseroth, A. B. and Estrov, Z. (1996). Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors. Leukemia, 10, 757-765.
16. Aronica, S. M., Mantel, C., Gonin, R., Marshall, M. S., Sarris, A., Cooper, S., Hague, N., Zhang, X. F. and Broxmeyer, H. E. (1995). Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J Biol Chem, 270, 21998-22007.
17. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H. and Tosato, G. (1995). Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med, 182, 155-62.
18. + lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood, 86, 651-8.
19. Sarris, A. H., Daliani, D., Ulmer, R., Crow, M., Broxmeyer, H. E., Pugh, W., Reiss, M., Cabanillas, F., Deisseroth, A. B. and Duvic, M. (1996). Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leukemia & Lymphoma, 24, 103-110.
20. Sarris, A. H., Daliani, D., Ulmer, R., Crow, B., Broxmeyer, H. E., Reiss, M., Karasavvas, N., Zelenets, A. D., Pugh, W., Cabanillas, F., Deisseroth, A. B., Duvic, M. (1997). Interferon-inducible Protein-10 as a Possible Factor in the Epidermotropism of Cutaneous T-cell Lymphomas. Clinical Cancer Research, 3:
21. Jackow, C. M., Cather, J. C., Hearne, V., Asano, A. T., Musser, J. M. and Duvic, M. (1997). Association of erythrodermic cutaneous T cell lymphoma, superantigen-positive Staphylococcus Aureus and oligoclonal T-cell receptor Vβ gene expression. Blood, 89, 32-40.
22. Tan, R. S., Butterwoth, C. M., McLaughlin, H., Malka, S., Samman, P. D. (1974). Mycosis fungoides - a disease of antigen persistence. Br J Dermatol, 91, 607-16.
23. Narumi, S. and Hamilton, T. A. (1991). Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. J Immunol, 146, 3038-44.
24. Gomez, C. M., Hamilton, T. A., Egido, J. and Emancipator, S. N. (1993). Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. Am J Pathol, 142, 433-9.
25. Ohmori, Y. and Hamilton, T. A. (1994). Cell type and stimulus specific regulation of chemokine gene expression. Biochem Biophys Res Commun, 198, 590-6.
26. Namuri, S., Wyner, L. M., Stoler, M. H., Tannenbaum, C. S. and Hamilton, T. A. (1992). Tissue-specific expression of murine IP-10 mRNA following systemic treatment with Interferon gamma. J Leukoc Biol, 52, 27-33.
27. Ohmori, Y., Wyner, L., Narumi, S., Armstrong, D., Stoler, M. and Hamilton, T. A. (1993). Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol, 142, 861-70.
28. Vanguri, P. and Farber, J. M. (1994). IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia. J Immunol, 152, 1411-8.
29. Grassmann, R., Berchtold, S., Radant, I., Alt, M., Fleckstein, B., Sodroski, J. G., Haseltine, W. A. and Ramstedt, U. (1992). Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol, 66, 4570-5.
30. Brown, D. A., Nelson, F. B., Reinherz, E. L. and Diamond, D. J. (1991). The human interferon-gamma gene contains an inducible promoter that can be transactivated by tax I and II. Eur J Immunol, 21, 1879-85.
31. Mori, N. and Prager, D. (1996). Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus type I and type II Tax proteins.Blood, 87, 3410-7.
32. Hall, W. W., Liu, C. R., Schneewind, O., Takahashi, H., Kaplan, M. H., Roupe, G. and Vahlne, A. (1991). Deleted HTLV-1 provirus in blood and cutaneous lesions and patients with mycosis fungoides. Science, 253, 317-20.
33. Pancake, B. A. and Zucker, F. D. (1993). HTLV tax and mycosis fungoides [letter]. N Engl J Med, 329, 580.
34. Ghosh, S. K., Abrams, J. T., Terunuma, H., Vonderheid, E. C. and De Freitas, E. (1994). Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma, Blood, 84, 2663-71.
35. Manca, N., Piacentini, E., Gelmi, M., Calzavara, P., Manganoni, M. A., Glukhoy, A., Gargiulo, F., De Francesco, M., Pirali, F., De Panfilis, G., Turano, A. (1994). Persistence of human T-cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides. J Exp Med, 180, 1973-8.
36. Pancake, B. A., Zucker-Franklin, D. and Coutavas, E. E. (1995). The cutaneous T-cell lymphoma, mycosis fungoides, is human T-cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest, 95, 547-54.
37. Li, G., Vowels, V. R., Benoit, B. M., Rook, A. H. and Lessins, S. R. (1996). Failure to detect human T-lymphotrophic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Investigate Dermatology, 107, 308-313.
38. Lisby, G., Reitz, M. S., Jr. and Vejlsgaard, G. L. (1992). No detection of HTLV-I DNA in punch skin biopsies from patients with cutaneous T-cell lymphoma by the polymerase chain reaction. J Invest Dermalol, 98, 417-20.
39. Wood, G. S., Salvekar, A., Schaffer, J., Crooks, C. F., Henghold, W., Finenson, D. P., Kim, Y. H. and Smaller, D. R. (1996). Evidence against a role for human T-cell lymphotropic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Investigative Dermatology, 107, 301-307.
40. Kikuchi, A., Nishikawa, T., Ikeda, Y. and Yamaguchi, K. (1997). Absence of Human T-Lymphotropic Virus Type 1 in Japanese Patients with Cutaneous T-Cell Lymphoma. Blood, 89, 1529-1532.
41. Cabanillas, F., Armitage, J., Pugh, W. C., Weisenburger, D. and Duvic, M. (1995). Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma. Annals of Internal Medicine, 122, 210-217.
42. Beljaards, R. C., Kaudewitz, P., Berti, E., Gianotti, R., Neumann, C., Rosso, R., Paulli, M., Meijer, C. J. and Willemze, R. (1993). Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer, 71, 2097-104.
43. Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., Glatstein, E., Ihde, D. C., Kaye, F., Veach, S. R., Phelps, R., O'Connor, T., Trepel, J. B., Cotelingam, J. D., Gazdar, A. F., Minna, J. D. and Bunn, P. A. J. (1988). Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med, 109, 372-82.
44. Busch, M. P., Laycock, M., Kleinman, S. H., Wages, J. W., Jr., Calabro, M., Kaplan, J. E., Khabbaz, R. F. and Hollingsworth, C. G. (1994). Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood, 83, 1143-8.
45. Chomezynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem, 162, 156-9.
46. Sarris, A. H. and Palade, G. E. (1982). Isolation and partial characterization of the sialoglycoprotein fraction of murine erythrocyte ghosts. J Cell Biol, 93, 583-90.
47. Gansbacher, B., Zier, K., Cronin, K., Hantzopoulos, P. A., Bouchard, B., Houghton, A., Gilboa, E. and Golde, D. (1992). Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood, 80, 2817-25.
48. Diem, K. and Lentner, C., (eds.), (1974). Scientific Tables. Documenta Geigy, eds., (Geigy Pharmaceuticals Ardsley, New York.)
49. Vowels, B. R., Lessin, S. R., Cassin,M., Jaworsky, C., Benoit, B., Wolfe, J. T. and Rook, A. H. (1994). Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol, 103, 669-73.
50. Ohmori, Y. and Hamilton, T. A. (1995). The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol, 154, 5235-44.
51. Boorsma, D. M., de Haan, P., Willemze, R. and Stoof, T. J. (1994). Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-gamma-inducible protein (gamma-IP-10) gene expression in cultured normal human keratinocytes. Arch Dermatol Res, 286, 471-5.
52. Cooper, D. L., Braverman, I. M., Sarris, A. H., Durivage, H. J., Saidman, B. H., Davis, C. A. and Hait, W. N. (1993). Cyclosporine treatment of refractory T-cell lymphomas. Cancer, 71, 2335-41.
53. Penix, L., Weaver, W. M., Pang, Y., Young, H. A. and Wilson, C. B. (1993). Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J Exp Med, 178, 1483-96.
54. Anagnostopoulos, I., Hummel, M., Kaudewitz, P., Herbst, H., Braun-Falco, O. and Stein, H. (1990). Detection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphomas. Am J Pathol, 137, 1317-22.
55. Weiss, L. M., Wood, G. S., Hu, E., Abel, E. A., Hoppe, R. T. and Sklar, J. (1989). Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome. J Invest Dermatol, 92, 601-4.